...Rong Cao; Jiao Zhao; Jingru Zhang Objectives: Long intergenic nonprotein coding RNA 1857 (LINC01857) has been identified to play an oncogenic role in different cancers. Nevertheless, its expression and biological role in endometrial carcinoma (EC) are not clear. Design: This study was a basic...

...Xiao-fei Sun; Shu-yan Dai Objectives: To explore the expression of Galectin-1 and -9 and clinicopathological features in endometrial carcinoma (EC). Methods: Normal endometrium (NE), atypical endometrial hyperplasia (AH), and endometrial cancer were collected, and immunohistochemistry was used...

...Aharon Feldman; Sadaf Chaugle; Charlotte Burmeister; Adnan Munkarah; Mohamed A. Elshaikh Objective: To compare survival endpoints between African American (AA) and non-AA (NAA) women with endometrial carcinoma (EC) stage I–II using a robust matching analysis. Methods and Materials: Patients were...

...Ahmed I. Ghanem; Ankit Modh; Charlotte Burmeister; Adnan R. Munkarah; Mohamed A. Elshaikh Objectives: We sought to evaluate the impact of age-adjusted Charlson comorbidity index (AACCI) score on survival endpoints for women with advanced stage endometrial carcinoma (EC). Methods and Materials: We...

...Huizhen Sun; Li Yan; Ruiqin Tu; Yuqin Zhang; Li Ma; Wenbin Tang; Long Li; Wei Chen; Cheng Zhan; Rongyu Zang Background: This study was to explore the expression profile of endometrial carcinoma (EC) and identify the potential molecular mechanism and therapeutic targets. Methods: Differentially...

...Pedro Acién; Irene Velasco; Maribel Acién; Cecilia Capello; Pilar Vela Aims: To determine the prevalence of endometriosis in epithelial ovarian cancers (EOC) and the association among their histological subtypes and with endometrial carcinoma. Methods: An observational cohort study performed in 192...

... atypical complex hyperplasia (ACH) and to develop a model predicting the probability of the presence of endometrial carcinoma in ACH. Methods: Patients (n = 128) who underwent total hysterectomies because of diagnoses of ACH were evaluated at four tertiary centers. Results: Diagnoses made using frozen...

... endometrial carcinoma tissues to understand the relationship between its expression and clinicopathological characteristics. Methods: ER-α36 expression was assessed by immunostaining in 73 endometrial carcinomas, 20 normal endometrial tissues, and 9 with atypical endometrial hyperplasia. Correlations between...

...) and progesterone receptor (PgR) levels in endometrial samples of these patients were estimated, and histological dating of the cycle day was carried out. Similarly, hormone serum levels and ER as well as PgR were estimated in 17 patients with endometrial carcinoma. No correlation between LH, FSH, HPRL and ER...

...C.Y. Genton; K.A. Büchi The histological and ultrastructural features of 15 endometrial carcinomas were analyzed and recorded without knowledge of the steroid receptor content which was determined in the cytosol of the tumor tissue. Serum levels of estrogens were determined in all patients...

...Pierluigi Benedetti Panici; Pier Franco Di Roberto; Pasquale Alessandro Margariti; Giovanni Scambia; Adriano Bompiani; Salvatore Mancuso The authors have re-examined 146 patients with stage I and II endometrial carcinoma according to pathological findings. An understaging of FIGO classification...

...David Levran; Michaela Modan; Joseph Menczer; Mordechai Dulitzy Glycosylated hemoglobin was compared in 22 unselected endometrial carcinoma cases 1–10 years (mean ± SD = 3.3 + 2.8) after diagnosis and in 939 controls, a representative population sample in the same age range tested for oral glucose...

...Zoltá;n Szarvas; Bé;la Zsolnai; Gá;bor Gimes; Judit Hidvégi The morphological effect of a high-dose progestogen (Depo-Provera) on highly differentiated endometrial carcinoma was studied. Thirteen patients were treated by progestogen only, given at the beginning ofthe treatment in a weekly dose...

...N. Crona; L. Enk; L.G. Friberg; G. Samsioe; G. Silfverstolpe 21 women (mean age 60 years, range 48–72) were given depot medroxyprogesterone acetate (DMPA), 1,000 mg/week parenterally for 6 months, as part of the treatment for endometrial carcinoma in either clinical stage I or II. Before treatment...

... a panel of monoclonal antibodies. The results indicated that normal endometrium mostly lacked the expression of these sugar structures. In endometrial carcinoma, the expression of H, Lewis a , Lewis b was evident and type 1 core chain was observed only after neuraminidase pretreatment. These data...

...Chyong-Huey Lai; Chin-Yi Wang; Chieh-Yu Lin; Chia C. Pao The presence of human papillomavirus (HPV) type 16 and 18 transcripts was determined by reverse transcription/polymerase chain reaction (PCR) in ovarian and endometrial carcinoma tissue. HPV-16 DNA sequences were detected in 50.0% (9/18...

...Ryou Misao; Atsushi Imai; Keisuke Wada; Teruhiko Tamaya Estrone (E 1 ), a principal estrogen in postmenopausal women, may have profound consequences in the maintenance and progression of hormone-sensitive endometrial carcinoma. This study was designed to investigate the specific binding sites for E...

...Daisuke Doi; Daisuke Doi; Tsutomu Araki; Tsutomu Araki; Goro Asano; Goro Asano Tenascin is an extracellular matrix glycoprotein which plays a role in cell attachment, proliferation and migration. To elucidate the function of tenascin in the proliferation of endometrial carcinoma, we studied...

... and UPSC tumors. 17 12 2007 3 06 2008 9 10 2008 Sulfatase Endometrium Endometrial carcinoma Dehydroepiandrosterone sulfate © 2008 S. Karger AG, Basel 2008 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...

...Peter Uharček; Miloš Mlynček; Jozef Ravinger Background: Gynecologic cancers metastatic to bone are rare. Endometrial carcinoma usually presents with vaginal bleeding. Case Report: A 67-year-old woman presented with pain, erythema and swelling of the right foot and no history of postmenopausal...